Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Kahn to Neoplastic Stem Cells

This is a "connection" page, showing publications Michael Kahn has written about Neoplastic Stem Cells.

 
Connection Strength
 
 
 
1.484
 
  1. Zhao Y, Wu K, Wu Y, Melendez E, Smbatyan G, Massiello D, Kahn M. Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists. Curr Mol Pharmacol. 2018; 11(2):113-121.
    View in: PubMed
    Score: 0.406
  2. Kim YM, Gang EJ, Kahn M. CBP/Catenin antagonists: Targeting LSCs' Achilles heel. Exp Hematol. 2017 08; 52:1-11.
    View in: PubMed
    Score: 0.388
  3. Duchartre Y, Kim YM, Kahn M. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells. Methods Mol Biol. 2017; 1613:463-478.
    View in: PubMed
    Score: 0.379
  4. Belur Nagaraj A, Knarr M, Sekhar S, Connor RS, Joseph P, Kovalenko O, Fleming A, Surti A, Nurmemmedov E, Beltrame L, Marchini S, Kahn M, DiFeo A. The miR-181a-SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer. Cancer Res. 2021 04 15; 81(8):2044-2055.
    View in: PubMed
    Score: 0.126
  5. Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX, Ivy SP. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015 Aug; 12(8):445-64.
    View in: PubMed
    Score: 0.084
  6. Pohl A, Lurje G, Kahn M, Lenz HJ. Stem cells in colon cancer. Clin Colorectal Cancer. 2008 Mar; 7(2):92-8.
    View in: PubMed
    Score: 0.051
  7. Chan LS, Lung HL, Ngan RK, Lee AW, Tsao SW, Lo KW, Kahn M, Lung ML, Wieser R, Mak NK. Role of miR-96/EVI1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation. Int J Mol Sci. 2020 Jul 31; 21(15).
    View in: PubMed
    Score: 0.030
  8. Chan KC, Chan LS, Ip JC, Lo C, Yip TT, Ngan RK, Wong RN, Lo KW, Ng WT, Lee AW, Tsao GS, Kahn M, Lung ML, Mak NK. Therapeutic targeting of CBP/ß-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Sci Rep. 2015 Apr 21; 5:9979.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)